<div id="readability-page-1">11:17 AM EST, 12/12/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Friday morning, falling 1% to 1,646.41 on the S&amp;P Europe Select ADR Index, which is up 1.3% so far this week.From continental Europe, the gainers were led by telecommunications operator Telefonica ( TEF ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 1.5% and 1% respectively. They were followed by energy company Equinor ( EQNR ) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical companies Cellectis ( CLLS ) and DBV Technologies ( DBVT ) , which fell 8.4% and 3.1% respectively. They were followed by telecommunications company Nokia ( NOK ) and medical device maker EDAP TMS ( EDAP ) , which were down 2.6% and 0.6% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 8.3% and 1.9% respectively. They were followed by software firm Endava ( DAVA ) and hospitality company InterContinental Hotels Group ( IHG ) , which increased 1.7% and 1.1% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and tobacco company British American Tobacco ( BTI ) , which lost 11.9% and 3.2% respectively. They were followed by insurance company Prudential (PUK) and lender Lloyds Banking Group ( LYG ) , which dropped 2.4% and 1.7% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AKTX

DBVT

ASND

BDRX

European equities traded as American Depositary Receipts in the US fell 1% on Friday, despite being up 1.3% for the week. Notable gainers included Telefonica, Ascendis Pharma, Equinor, and Novo Nordisk. Decliners included Cellectis, DBV Technologies, Nokia, and EDAP TMS. In the UK and Ireland, Akari Therapeutics and Autolus Therapeutics led gains, while Biodexa Pharmaceuticals and British American Tobacco saw significant declines.

fidelity

Akari Therap

DBV Tech

Ascendis Pharmac

Biodexa Pharmaceuticals

British American Tobacco

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week